Tahoe Therapeutics Company
Tahoe Therapeutics develops AI-powered tools to simulate human cell responses and guide drug discovery. It operates a platform called Mosaic that produces large-scale single-cell datasets detailing how drug molecules interact with diverse patient cells, with initial applications in oncology. It open-sources its Tahoe-100M dataset, comprising hundreds of millions of single-cell profiles, to train AI models that build virtual cell models for therapeutic insights. A recent funding round enabled the creation of an even larger dataset, targeting one billion cell datapoints and one million drug-patient interactions, designed to fuel next-generation precision medicines
Founded Date:
2022-01-01
Last Funding Date:
2025-08-11
Industry:
Quantum Biology
Total Funding:
42000000
Headquarters:
South San Francisco,California,United States,North America
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
42000000
Last Funding Total Usd:
30000000
Last Funding Total Currency:
USD
Last Funding Total Value:
30000000
Founders:
Hani Goodarzi,Johnny Yu,Kevan Shokat,Nima Alidoust